Stem cell legend attracts $40M round for preclinical testing tech

Madison, WI-based Cellular Dynamics International has raised a $40.6 million Series B to expand on the commercialization of its work harvesting human stem cell lines for preclinical drug testing. Founded by stem cell legend James Thomson from the University of Wisconsin, Cellular Dynamics--a 2008 Fierce 15 company--has been a pioneer in the move to use stem cell technology for more accurate preclinical drug testing. "We have strong demand from pharmaceutical companies for live heart...